Wuxi Biologics has reported a full-year net income of 3.40 billion yuan, falling short of the estimated 3.58 billion yuan. The company’s revenue exceeded estimates, coming in at 17.03 billion yuan against an estimated 16.98 billion yuan. Adjusted net income surpassed estimates, with Wuxi Biologics reporting 4.70 billion yuan against an estimated 4.2 billion yuan. The gross margin for the c...
Analyst sentiment towards WuXi AppTec has declined, with significant cuts to revenue estimates and EPS numbers. The company's revenues are forecast to shrink, indicating a significant reduction from annual growth of 31% over the last five years.
$Lion-OCBC Sec HSTECH S(HST.SG)$ Hong Kong stocks slipped, extending a retreat from a three-month high, as weak corporate earnings and guidance weighed on sentiment and Chinese authorities stayed away from major stimulus measures to rejuvenate the economy. The Hang Seng Index declined 1.1 per cent to 16,550.90 at the local noon trading break. The Tech Index fell 1.8 per cent, while the ...
102884128 : what is your entry?
HappyGotLuckyスレ主 102884128: I sold at ard 39 and now back to the game at 35.9. Will start from here and DCA down.